摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+)-tedanalactam | 1184869-42-8

中文名称
——
中文别名
——
英文名称
(+)-tedanalactam
英文别名
(3R,4R)-epoxy-2-piperidone;cis-3,4-Epoxypiperidin-2-one;(1R,6R)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one
(+)-tedanalactam化学式
CAS
1184869-42-8
化学式
C5H7NO2
mdl
——
分子量
113.116
InChiKey
PHTVNQOAOFDDIK-QWWZWVQMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    41.6
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    (+)-tedanalactam3-(3,4-dimethoxy-phenyl)-propionyl chloride正丁基锂 作用下, 以 四氢呋喃 为溶剂, 反应 6.67h, 以17 mg的产率得到(-)-piplaroxide
    参考文献:
    名称:
    Tedanalactam对映异构体的合成和(+)-Piplaroxide的第一个全合成和构型分配
    摘要:
    突显了最近建立的从叔烯丙基胺直接合成缩水甘油酰胺的方法,从相应的手性二氢哌啶中分两步完成了他那拉坦对映体的合成。另外,从它们各自的他达那他坦前体中获得了吡哌醇氧化物的(+)-和(-)-对映异构体,并确定了天然存在的(+)-吡哌醇氧化物的绝对构型。本方法不仅代表了最短的(-)-tedanalactam合成,而且代表了第一个总的(+)-piplaroxide合成,这是一种对切叶蚁Atta cephalotes的驱避剂。
    DOI:
    10.1021/acs.jnatprod.5b01041
  • 作为产物:
    描述:
    (1R,6R)-3-[(S)-1-(4-methoxyphenyl)ethyl]-7-oxa-3-azabicyclo-[4.1.0]heptan-2-one 在 ammonium cerium (IV) nitrate 作用下, 以 乙腈 为溶剂, 反应 4.0h, 以0.185 mg的产率得到(+)-tedanalactam
    参考文献:
    名称:
    Tedanalactam对映异构体的合成和(+)-Piplaroxide的第一个全合成和构型分配
    摘要:
    突显了最近建立的从叔烯丙基胺直接合成缩水甘油酰胺的方法,从相应的手性二氢哌啶中分两步完成了他那拉坦对映体的合成。另外,从它们各自的他达那他坦前体中获得了吡哌醇氧化物的(+)-和(-)-对映异构体,并确定了天然存在的(+)-吡哌醇氧化物的绝对构型。本方法不仅代表了最短的(-)-tedanalactam合成,而且代表了第一个总的(+)-piplaroxide合成,这是一种对切叶蚁Atta cephalotes的驱避剂。
    DOI:
    10.1021/acs.jnatprod.5b01041
点击查看最新优质反应信息

文献信息

  • Total Synthesis of (−)- and (+)-Tedanalactam
    作者:Mahesh S. Majik、Perunninakulath S. Parameswaran、Santosh G. Tilve
    DOI:10.1021/jo901143b
    日期:2009.8.21
    The first stereoselective route providing access to both enantiomers of tedanalactam. a naturally occurring piperidone, has been developed. The stereogenic centers were generated by the use of Sharpless asymmetric dihydroxylation. Tandem oxidation-Wittig reaction and one-pot deprotection, lactamization, and oxirane ring formation are the other key elements.
查看更多

同类化合物

7-亚乙基-环戊二烯并(b)环氧乙烷并(c)吡啶六氢衍生物. 4-甲基-3-氧杂-6-氮杂三环[3.2.0.02,4]庚烷-7-酮 3-氧杂-6-氮杂三环[3.2.2.02,4]壬烷(8CI,9CI) 3-氧杂-1-氮杂三环[5.2.0.02,4]壬烷 2-氧杂-6-氮杂三环[4.3.1.01,3]癸烷 (1S,2R,4S,5R)-3-氧杂-6-氮杂三环[3.2.1.02,4]辛烷-7-酮 (5R,7S,8R,8aR)-5-dodecyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one (2S,2R,4S,5R,6S)-(+)-2-{2-[2-[1,3]-dioxolan-2-yl-ethyl]-6-methyl-4,5-epoxy-3,6-dihydro-2H-pyridin-1-yl}-2-phenylethanol (5R,7R,8S,8aR)-5-ethyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one dihydroabikoviromycin (1R,6R)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6S)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1aR,6aS,7R,7aS)-7-(t-butyldimethylsilyloxy)tetrahydro-1aH-oxazolo[3,4-a]oxireno[2,3-d]pyridin-4(2H)-one 11-formyl-(1rN,2tH,4tH,6cN,7tH,9tH)-3,8-dioxa-11-aza-tetracyclo[4.4.1.02,4.07,9]undecane 7-Oxa-2-azabicyclo[4.1.0]heptane (1S,6S)-1-(hydroxymethyl)-3-[(1R)-2-hydroxy-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-1-(hydroxymethyl)-3-[(1R)-2-hydroxy-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-3-[(1R)-2-[tert-butyl(dimethyl)silyl]oxy-1-phenylethyl]-1-(hydroxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6S)-3-[(1R)-2-[tert-butyl(dimethyl)silyl]oxy-1-phenylethyl]-1-(hydroxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one 3-Oxa-10-azatricyclo[4.3.1.0~2,4~]decane (3S,5R,6R,7R)-6-hydroxy-4,9-dioxa-1-azatricyclo[5.3.0.03,5]decan-10-one (1RS,2SR,4RS,5SR)-3-oxa-6-azatricyclo[3.2.1.02,4]octan-7-one (1S,6S)-1-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one 3-(methanesulfonyl)-7-oxa-3-azabicyclo[4.1.0]heptane 3α,4α-epoxy-2-piperidone (+)-tedanalactam 5-amino-1,2-anhydro-5-deoxy-D-lyxono-1,4-lactame (1R,5S,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,5R,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6R)-4,4,6-trimethyl-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6S)-4,4,6-trimethyl-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-3-(cyclopropylmethyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-ethyl-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-(2-methylpropyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-(2-methoxyethyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-methyl-7-oxa-3-azabicyclo[4.1.0]heptane (1S,6S)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6S)-7-oxa-2-azabicyclo[4.1.0]heptane (1S,6R)-7-oxa-2-azabicyclo[4.1.0]heptane (1R,6R)-7-oxa-3-azabicyclo[4.1.0]heptane (1S,2S,4R,5S)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (2R,4S,7S)-3-oxa-1-azatricyclo[5.2.0.02,4]nonane (1S,2S,4S,5R)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1S,2S,4S,5S)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (2S,4R,7S)-3-oxa-1-azatricyclo[5.2.0.02,4]nonane (1R,6R)-1-methyl-3-propyl-7-oxa-3-azabicyclo[4.1.0]heptane (1S,2R,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1R,2S,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1S,2S,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1R,6S)-3-methyl-7-oxa-3-azabicyclo[4.1.0]heptane